The type 2 cannabinoid receptor (CB2) protects against age-related osteoporosis by affecting bone formation and CB2 agonists exhibit anabolic activity in vivo

A. Sophocleous, E. Landao-Bassonga, R. van't Hof, S. H. Ralston, A. I. Idris

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)S219-S219
Number of pages1
JournalBone
Volume44
Issue number2
DOIs
Publication statusPublished - Jun 2009

Cite this